Antidepressant medications list
Pro Research Analysisby 
Searched over 200M research papers
Common Antidepressant Medications: SSRIs, SNRIs, TCAs, and MAOIs
The most widely used antidepressant medications include several main classes: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). SSRIs, such as sertraline, are the most commonly prescribed due to their favorable side effect and tolerability profile compared to older medications like TCAs and MAOIs, which are associated with more significant side effects such as weight gain, dry mouth, and risk of dangerous interactions 467. SNRIs, such as venlafaxine and desvenlafaxine, are also commonly used and can be effective for patients who do not respond to SSRIs 17. TCAs and MAOIs are generally reserved for cases where other treatments have failed due to their side effect profiles 68.
Atypical and Newer Antidepressants: Bupropion, Mirtazapine, Trazodone, Vortioxetine, Vilazodone
Several antidepressants do not fit into the traditional classes and are considered atypical or newer agents. These include:
- Bupropion: Works on norepinephrine and dopamine, with no significant effect on serotonin. It is also used for smoking cessation 27.
- Mirtazapine: Enhances norepinephrine and serotonin neurotransmission and is known for its sedative effects and potential for weight gain 27.
- Trazodone: Acts as a serotonin antagonist and reuptake inhibitor, often used off-label for insomnia due to its sedative properties 27.
- Vortioxetine: A newer antidepressant that modulates several serotonin receptors and is associated with improvements in cognitive symptoms of depression 23.
- Vilazodone: Functions as an SSRI and partial agonist at serotonin receptors, with a potentially faster onset and fewer sexual side effects 123.
Rapid-Acting and Emerging Antidepressants: Ketamine, Esketamine, and Others
Recent research has focused on rapid-acting antidepressants for patients who do not respond to traditional medications. Ketamine and its derivative esketamine, which act on glutamatergic neurotransmission, have shown promise for rapid symptom relief, especially in treatment-resistant depression 15. Other agents under investigation include scopolamine, psilocybin, and novel compounds targeting different neurotransmitter systems 15.
Augmentation and Add-On Therapies
For patients who do not achieve full remission with standard antidepressants, augmentation strategies are sometimes used. These can include second-generation antipsychotics (such as aripiprazole and quetiapine), as well as various nutraceuticals and over-the-counter agents like S-adenosylmethionine, folate, omega-3 fatty acids, and others, which may enhance the effectiveness of antidepressant therapy 19.
Conclusion
The list of antidepressant medications is extensive and includes SSRIs (e.g., sertraline), SNRIs (e.g., venlafaxine, desvenlafaxine), TCAs, MAOIs, and atypical agents such as bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. Newer and rapid-acting agents like ketamine and esketamine are expanding treatment options, especially for those with treatment-resistant depression. The choice of medication depends on individual patient needs, side effect profiles, and response to previous treatments 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic